Loading organizations...
Loading organizations...
Biopharmaceutical company targeting unmet needs in oncology.
Nuvation Bio has raised $375.0M across 2 funding rounds.
Nuvation Bio has raised $375.0M in total across 2 funding rounds.
Nuvation Bio has raised $375.0M in total across 2 funding rounds.
Nuvation Bio's investors include Sagard, Omega Funds.
Nuvation Bio has raised $375.0M across 2 funding rounds. Most recently, it raised $100.0M Debt in March 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 3, 2025 | $100.0M Debt | Sagard | |
| Oct 28, 2019 | $275.0M Series A | Omega Funds |